Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-2-24
pubmed:abstractText
We conducted a phase II feasibility study using preoperative chemotherapy with cisplatin and docetaxel followed by surgical resection and postoperative chemoradiation in patients with gastric or gastroesophageal cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1534-4681
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
677-83
pubmed:meshHeading
pubmed-meshheading:21063792-Adenocarcinoma, pubmed-meshheading:21063792-Adult, pubmed-meshheading:21063792-Aged, pubmed-meshheading:21063792-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21063792-Carcinoma, Squamous Cell, pubmed-meshheading:21063792-Cisplatin, pubmed-meshheading:21063792-Combined Modality Therapy, pubmed-meshheading:21063792-Esophageal Neoplasms, pubmed-meshheading:21063792-Esophagogastric Junction, pubmed-meshheading:21063792-Feasibility Studies, pubmed-meshheading:21063792-Female, pubmed-meshheading:21063792-Humans, pubmed-meshheading:21063792-Male, pubmed-meshheading:21063792-Middle Aged, pubmed-meshheading:21063792-Neoplasm Recurrence, Local, pubmed-meshheading:21063792-Neoplasm Staging, pubmed-meshheading:21063792-Postoperative Care, pubmed-meshheading:21063792-Preoperative Care, pubmed-meshheading:21063792-Radiotherapy Dosage, pubmed-meshheading:21063792-Stomach Neoplasms, pubmed-meshheading:21063792-Survival Rate, pubmed-meshheading:21063792-Taxoids, pubmed-meshheading:21063792-Treatment Outcome
pubmed:year
2011
pubmed:articleTitle
Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
pubmed:affiliation
Division of Haematology and Oncology, Department of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria.
pubmed:publicationType
Journal Article, Clinical Trial, Phase II